Flash nanoprecipitation process for encapsulating active agents in tunable zein nanoparticles

Background

The field of nanoparticle encapsulation is critical for developing advanced delivery systems in pharmaceuticals, nutraceuticals, agrochemicals, and cosmetics. Encapsulating active ingredients protects sensitive compounds, masks undesirable tastes, and improves targeted therapeutic delivery. As industries increasingly prioritize consumer safety and environmental sustainability, there is a growing need to transition away from synthetic materials and utilize natural, biodegradable alternatives that are generally recognized as safe. Consequently, a significant demand exists for scalable, cost-effective manufacturing processes capable of producing stable nanoparticles with high encapsulation efficiency and controlled sizes to meet rigorous industrial standards.

Despite this demand, current approaches to nanoparticle fabrication face substantial limitations. Traditional methods heavily rely on synthetic polymers, which are often expensive and require extensive regulatory approvals. While natural protein polymers offer a promising alternative, their industrial application is severely hindered by inherent physical challenges, particularly a high propensity for uncontrolled aggregation and premature precipitation. Furthermore, conventional manufacturing techniques—such as solvent evaporation, spray-drying, and supercritical antisolvent precipitation—struggle to overcome these material constraints. These existing processes suffer from poor scalability and low reproducibility, failing to provide the precise control over particle size required for reliable commercial production.

Technology

This nano-encapsulation platform utilizes flash nanoprecipitation within a multi-inlet vortex mixing apparatus to produce highly controlled nanoparticles. By rapidly combining fluid streams of zein in hydroalcoholic solutions, active agents in organic solvents, and aqueous buffers, the system generates particles with tunable diameters between 10 and 500 nanometers. The process yields versatile architectures, including core-shell composites and inverse nanoparticles. It achieves exceptional performance, boasting encapsulation efficiencies exceeding 98% and supporting additive loading up to 60% by weight. These nanoparticles are stabilized against aggregation in physiological environments through the strategic incorporation of surfactants like sodium caseinate.

This solution is highly differentiated by its use of natural, biodegradable maize proteins classified as “generally recognized as safe” (GRAS), bypassing the regulatory hurdles and costs of synthetic polymers. While traditional zein-based methods struggle with aggregation and poor scalability, this continuous-flow approach ensures precise size control, low polydispersity, and high reproducibility. The platform uniquely maintains structural integrity and bioactivity across extreme conditions, including high temperatures, acidic gastric environments, and freeze-drying. By offering a scalable, cost-effective method that outperforms conventional techniques like spray-drying, this technology provides an ideal delivery system for pharmaceuticals, nutraceuticals, and agrochemicals.

Benefits

• Utilizes natural, low-cost, and FDA-approved GRAS (Generally Recognized As Safe) materials like zein, providing a safer alternative to expensive synthetic polymers.
• Offers a highly scalable, reproducible, and cost-effective manufacturing process suitable for both continuous and batch production.
• Achieves exceptional encapsulation efficiencies exceeding 98% and supports high active agent loading capacities of up to 60% by weight.
• Provides precise control over nanoparticle architecture, yielding uniform particles with tunable sizes (10 to 500 nanometers) and low polydispersity.
• Demonstrates broad versatility by successfully encapsulating a wide range of hydrophobic and hydrophilic compounds, including pharmaceuticals, biomolecules, nutraceuticals, and agrochemicals.
• Ensures robust thermal and colloidal stability across various physiological environments, extreme pH levels (such as gastric conditions), and freeze-drying processes.
• Enables controlled release profiles, high bioactivity retention, and effective taste-masking for improved therapeutic, nutritional, and consumer applications.

Applications

• Pharmaceutical drug delivery systems
• Nutraceutical and vitamin encapsulation
• Controlled release agrochemical delivery
• Taste masking for oral medications
• Cosmetic active ingredient encapsulation

Additional info

This process employs flash nanoprecipitation via multi-inlet vortex mixing to fabricate zein-based nanoparticles. By rapidly merging hydroalcoholic protein streams, organic solvents containing active agents, and aqueous buffers, it generates tunable structures (10–500 nm) with low polydispersity. These architectures, including core-shell and inverse configurations, achieve over 98% encapsulation efficiency and 60% loading. Stabilized by sodium caseinate, these biocompatible carriers ensure colloidal stability for pharmaceutical, nutraceutical, and agrochemical delivery.